The increase in occurrence of infections due to opportunistic gram-negative bacilli in patients with impaired host defenses emphasizes the need for information on the antibiotic susceptibility of the organisms that colonize such patients. During a 20-month period, more than 100 pseudomonads which were not Pseudomonas aeruginosa were recovered from cancer patients at the Baltimore Cancer Research Center. These included P. fluorescens, P. putida, P. multivorans (cepacia), P. maltophilia, P. stutzeri, P. alcaligenes, and P. pseudoalcaligenes. Susceptibility tests with 12 antibiotics indicated that the intraspecies antibiograms for many of these species were more uniform than those of P. aeruginosa. The stability of susceptibility patterns allowed the antibiograms to be used as aids in the preliminary differentiation of these organisms. Variable antibiogram patterns were noted among certain species, i.e., P. fluorescens, P. stutzeri, and P. multivorans, whereas each of the other species had essentially one pattern. These in vitro studies showed that some of the Pseudomonas species other than P. aeruginosa were resistant to a number of antibiotics. Among these were antibiotics that are in general use for P. aeruginosa infections. Such differences in antibiotic susceptibilities emphasize the necessity for careful speciation of this group of microorganisms to assure proper epidemiological documentation of colonization and infection, as well as to ensure therapy with an antimicrobial agent to which the organism is susceptible in vitro.
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The occurrence of infections due to gramnegative bacilli, some of which were previously considered to be of little infectious significance, has increased in patients with serious underlying diseases (4, 5) . Although Pseudomonas aeruginosa and bacilli of the family Enterobacteriaceae have been the microorganisms most commonly responsible for this increase in infection, the incidence of patient colonization or infection, or both, by other less common gram-negative bacilli has also become more frequent (5) . Among these bacilli is a heterogeneous group of bacteria which frequently has been classified onlyj as Pseudomonas spp. other than P. aeruginosa. With the advent of more clearly defined criteria for the characterization of the genus Pseudomonas (7, 14-16, 22, 23) , proper speciation is now possible in the diagnostic laboratory.
During a 20-month period, 131 strains of Pseudomonas other than P. aeruginosa were recovered from clinical materials collected from 52 cancer patients at the Baltimore Cancer Research Center. This group included strains identified as P. multivorans (cepacia), P. maltophilia, P. putida, P. stutzeri, P. fluorescens, P. pseudoalcaligenes, and P. alcaligenes. Unlike P. aeruginosa, most of these species are usually considered to possess a low degree of pathogenicity and invasiveness. However, many of these organisms were recovered from patients who were on broadspectrum antibiotic regimens designed to treat gram-negative bacillary sepsis; such cancer patients generally have impaired host defenses and tend to become infected with their own endogenous flora. These factors emphasized a need for information on the antibiotic susceptibilities of "non-aeruginosa" pseudomonads so that immediate appropriate therapy could be instituted in the event that one of the organisms should cause clinical infection. The present study was undertaken to determine antibiograms for these species and to compare them with the susceptibility patterns found for P. aeruginosa.
MATERIALS AND METHODS
Antimicrobial susceptibility testing of 131 pseudomonads was performed by a slight modification of the Bauer-Kirby method (2) . Three drops of an 18- (2) . All strains were tested on at least two occasions.
RESULTS
A total of 64 strains of P. multivorans, 24 of P. maltophilia, 17 of P. putida, 13 (Table 2) . Antibiotic responses which all species shared with P. aeruginosa were resistance to ampicillin, cephalothin, and penicillin, and, with the excep- All Pseudomonas spp. except P. aeruginosa were resistant to streptomycin and carbenicilin, whereas the latter was intermediately susceptible and susceptible. Similarly, all species were resistant to chloramphenicol except for P. aeruginosa and P. maltophilia. Antibiotic susceptibility testing of different serological types of P. aeruginosa has shown that their antibiograms do not necessarily remain stable and that the method of using the antibiogram to establish similarity of infecting strains would not be feasible for P. aeruginosa (11) . However, it would appear that the antibiograms of the 5 "non-aeruginosa" species are relatively stable and their antibiograms could be used to determine interspecies similarities (Table 3) . Of the 24 strains of P. maltophilia, 20 gave a pattern in which only (Table 4 ). P. maltophilia was susceptible to chloramphenicol and colistin but resistant to kanamycin and tetracycline; its susceptibility to carbenicillin varied. Although the patterns "a" of P. putida and P. fluorescens were remarkably similar in their susceptibility to kanamycin and colistin and in their resistance to chloramphenicol and carbenicillin, P. putida was resistant to tetracycline whereas P. fluorescens was susceptible to this agent. Pattern "b" of P. fluorescens was susceptible to tetracycline but differed from pattern "a" in that it was also susceptible to chloramphenicol. P. stutzeri was susceptible to most of the antibiotics; only strains with pattern "b" showed resistance to chloramphenicol. All patterns of P. multivorans were characterized by resistance to colistin and carbenicillin. Strains with pattern "a" were also resistant to the other antibiotics as well. Strains with patterns "b," "c," and "d" were all susceptible to chloramphenicol. Moreover, pattern "c") was distinguished from pattern "d" by susceptibility to tetracycline in pattern "c" and kanamycin susceptibility in pattern "d." DISCUSSION P. aeruginosa infections in man have proven to be particularly recalcitrant to antibiotic therapy even though in vitro tests show these organisms to be susceptible to certain antibiotics, e.g., streptomycin and chloramphenicol. More recently, therapy with carbenicillin and gentamicin, singly or in combination, (18) has proved to be clinically efficacious, and another new drug, nebramycin (17), holds promise. As the incidence of patient colonization with "non-aeruginosa" pseudomonads has increased, a comparison of the antibiotic susceptibilities of these organisms to those of P. aeruginosa was indicated. In vitro studies at the Baltimore Cancer Research Center showed that five "non-aeruginosa" species, i.e., P. multivorans (cepacia), P. maltophilia, P.
fluorescens, P. putida, and P. stutzeri, were resistant to a variety of antibiotics, including those presently known to be useful for clinical infection due to P. aeruginosa. P. maltophilia, a species (8, 12, 25) indicate that the susceptibility patterns of these five species can be used as an aid in their identification.
The change noted in P. multivorans from susceptibility to resistance to carbenicillin during the investigation may reflect the introduction of carbenicillin-gentamicin therapy for P. aeruginosa infections (18) . For approximately 1 year after initiation of such therapy in our hospital, only a few resistant strains were encountered. It is assumed that selection of resistant strains has occurred as only these strains were recovered from patients during the last 8 months of the study. An increased incidence of recovery was also noted. During this latter period, two carbenicillin-susceptible strains were recovered from the environment. Although P. multivorans has not caused proven infection thus far in our patients (it was recovered from the lungs of a patient at autopsy), it has been reported to cause human infection (1, 3, 9, 10, 13, 18, 21, 24) . The spread of this relatively resistant microorganism among high risk patients could conceivably be creating the appropriate circumstances needed for an opportunistic microorganism to become a new "hospital strain" capable of causing nosocomial infections.
The antibiograms of the Pseudomonas spp. studied clearly show great differences in their in vitro antibiotic susceptibilities. From the data presented, careful speciation of pseudomonads, especially those recovered from human clinical materials, in addition to antibiotic susceptibility testing, is essential for the effective control of these potentially infectious agents.
